Vnitr Lek 2015, 61(12):1001-1003

Fosfátová homeostáza při selhání ledvin je draze vykoupená maladaptivními systémovými důsledky extrémně vysokých koncentrací fosfatoninů - editorial

Sylvie Dusilová Sulková1,2
1 Hemodialyzační středisko FN Hradec Králové, vedoucí lékařka prof. MUDr. Sylvie Dusilová Sulková, DrSc., MBA
2 Katedra interních oborů LF UK Hradec Králové, vedoucí katedry prof. MUDr. Jan Bureš, CSc.

Received: September 28, 2015; Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dusilová Sulková S. Fosfátová homeostáza při selhání ledvin je draze vykoupená maladaptivními systémovými důsledky extrémně vysokých koncentrací fosfatoninů - editorial. Vnitr Lek. 2015;61(12):1001-1003.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Horáčková M, Schück O, Sotorník I et al. Vyšetřování tubulární resorpce fosfátů u pacientů s chronickým onemocněním ledvin. Vnitř Lék 2015; 61(12): 1034-1038. Go to PubMed...
    2. Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, a magnesium homeostasis. Clin J Am Soc Nephrol 2015; 10(7): 1257-1272. Go to original source... Go to PubMed...
    3. Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 2010; 21(9): 1427-1435. Go to original source... Go to PubMed...
    4. Gutiérrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359(6): 584-592. Go to original source... Go to PubMed...
    5. Heine GH, Seiler S, Fliser D. FGF-23: the rise of a novel cardiovascular risk marker in CKD. Nephrol Dial Transplant 2012; 27(8): 3072-3081. Go to original source... Go to PubMed...
    6. Negri AL. Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease. Int Urol Nephrol 2014; 46(1): 9-17. Go to original source... Go to PubMed...
    7. Seiler S, Rogacev KS, Roth HJ et al. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. Clin J Am Soc Nephrol 2014; 9(6): 1049-1058. Go to original source... Go to PubMed...
    8. Schlieper G, Schurgers L, Brandenburg V et al. Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant 2015; pii: gfv111. Dostupné z DOI: <http://dx.doi.org/10.1093/ndt/gfv111>. Go to original source... Go to PubMed...
    9. Kuro-O M. A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease. Kidney Int Kidney Suppl 2013; 3(5): 420-426. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.